microRNA-125b-5p mimic

microRNA-125b-5p mimic is an experimental synthetic oligonucleotide therapeutic designed to replicate the biological activity of the endogenous microRNA-125b-5p. As a microRNA mimic, it consists of a chemically synthesized double-stranded RNA duplex that, upon entering a cell, is processed into a functional single-stranded RNA that binds to the 3' untranslated regions (UTRs) of specific target mRNAs. This binding typically results in translational inhibition or mRNA degradation, thereby downregulating the expression of target proteins. In preclinical models of atherosclerosis, the mimic has been shown to downregulate the chemokine receptor CCR7, leading to increased plaque inflammation and progression. Conversely, in models of acute liver failure, it has been investigated for its ability to modulate the Keap1/Nrf2 pathway to reduce oxidative stress and inflammation. Other research has explored its role in targeting TRAF6 and IRF4 in conditions like multiple myeloma and myocardial infarction. There is currently no specific commercial developer or clinical-stage product associated with this compound.

Other names

miR-125b-5p mimicmiR125b-5p mimicmiR 125b-5p mimicmicroRNA-125b mimicmicroRNA125b mimicmicroRNA 125b mimicsynthetic miR-125b-5p duplex